Clearpoint Neuro Inc
(CLPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,525 | -7,086 | -5,878 | -8,311 | -9,454 |
| Depreciation Amortization | 708 | 570 | 2,478 | 1,715 | 1,156 |
| Accounts receivable | 301 | -325 | -44 | -370 | -32 |
| Other Working Capital | 1,240 | -2,052 | -6,361 | -633 | -245 |
| Other Operating Activity | -4,975 | 1,116 | 2,371 | 1,360 | 868 |
| Operating Cash Flow | $-7,250 | $-7,778 | $-7,434 | $-6,240 | $-7,707 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -75 | -128 | -26 | -62 |
| Purchase Sale Intangibles | N/A | -100 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -100 | 0 | 0 | 0 |
| Investing Cash Flow | $-48 | $-175 | $-128 | $-26 | $-62 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,503 | N/A | 3,425 | 2,000 | 3,777 |
| Common Stock Issued | 9,523 | 9,849 | 5,611 | 2,832 | 3,000 |
| Other Financing Activity | 0 | 0 | 0 | 2 | 0 |
| Financing Cash Flow | $13,026 | $9,849 | $9,036 | $4,834 | $6,777 |
| Beginning Cash Position | 3,516 | 1,620 | 146 | 1,577 | 2,569 |
| End Cash Position | 9,244 | 3,516 | 1,620 | 146 | 1,577 |
| Net Cash Flow | $5,728 | $1,896 | $1,475 | $-1,432 | $-992 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,250 | -7,778 | -7,434 | -6,240 | -7,707 |
| Capital Expenditure | -48 | -75 | -128 | -26 | -62 |
| Free Cash Flow | -7,298 | -7,852 | -7,561 | -6,266 | -7,769 |